Earnings to Watch – Week of 1 June 2026

Our readSame-store sales and the durability of the trade-down tailwind are the swing factors. Watch the traffic-versus-ticket split, gross-margin progression against the shrink-reduction program, and tariff pass-through – management has argued DG's direct-import exposure is limited and manageable, so any upward revision to the cost guide would pressure the FY26 EPS range. The read-across to Dollar Tree and the rest of this week's discount-retail cohort (Five Below, Ollie's) should be useful, though not one-for-one.

Our readConstant-currency sales growth for the February–April quarter is likely the first metric investors will check. Watch that first, the gross-margin line against the FX and tariff cost backdrop, and the early-summer trading update (1 May through early June) that Inditex typically discloses alongside Q1, a de-facto read on Spring/Summer 2026 sell-through against a tough +12% constant-currency year-ago comp. The debate is whether the re-acceleration is durable or whether currency and trade-war noise dents guidance despite resilient underlying demand. The read-across to H&M and the broader European discretionary tape should be meaningful.

Our readThe FY27 initial guide is likely the key element of the print. Watch whether Cardiovascular sustains its double-digit organic pace (PFA is the key share-gain engine against Boston Scientific's Farapulse), the Diabetes turnaround, the Hugo robotic-surgery ramp and Sphere-360 data as longer-term credibility markers, and whether the tariff headwind widens into FY27. The read-across to Boston Scientific, Abbott and the broader med-device group on PFA economics should be useful.

Our readAI semiconductor revenue against the $10.7bn guide is the first line to watch. After that, listen for any framing on the FY27 $100bn+ AI target, the XPU customer pipeline, the VMware and software-segment margin trajectory now that the integration is more mature, and management's read on hyperscaler capex into 2027. The read-through to NVIDIA, Marvell and the broader custom-silicon complex should be meaningful, but the customer mix is different enough to avoid treating it as a pure proxy.

Our readNet new ARR against the $249m floor is the swing factor. A miss would raise the worry that Falcon Flex pull-forward is masking demand softness; a beat would support the recovery narrative since the 2024 outage. Watch next-gen SIEM ARR (>$585m, +75% YoY in Q4) and Charlotte AI agentic adoption as the platform-expansion proof points, the $1m+ deal cohort, and any FY27 framing against the $6.47–$6.52bn full-year ARR guide. The read-through to SentinelOne (already reported), Zscaler and Fortinet is useful, with the usual caveat that each has a different product mix.

Our readRevenue execution against the $1.5bn Q2 guide – and whether backlog holds near $7bn – is the cleanest signal on whether the optical-upgrade cycle is still accelerating. Watch gross margin, the cloud-provider-versus-service-provider revenue split, and WaveLogic 6 competitive positioning as rivals narrow the coherent-throughput gap. Given the elevated re-rating, any guidance trim would likely be poorly received. The read-through from Broadcom's print the day before – and across to Coherent, Lumentum and the AI-networking complex – should be useful but not automatic.

Our readNorth America comps and gross-margin mitigation are the swing factors. Watch whether the China business (guided +25–30% in Q1) can offset the North America drag, the size of the realized tariff hit versus the mitigation offset, inventory discipline into the back half, and whether management holds or cuts the full-year $11.35–$11.50bn revenue guide. The recent settlement with founder Chip Wilson reduces the immediate proxy-fight overhang, but the board-refresh and product-strategy questions still raise the stakes on forward commentary. The read-across to Nike, the broader athletic-apparel group and the tariff-exposed retailers reporting this week should be useful.